[{"Assets_0_Q2_USD":74287576.0,"CommonStockSharesOutstanding_0_Q2_shares":102599258.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-10587846.0,"NetIncomeLoss_2_Q2_USD":-11665032.0,"NetIncomeLoss_1_Q2_USD":-5965140.0,"StockholdersEquity_0_Q2_USD":71062213.0,"Ticker":"CPRX","CIK":"1369568","name":"CATALYST PHARMACEUTICALS, INC.","OfficialName":"Catalyst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"872304311.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]